Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MTA”

857 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 857 results

Testing effectiveness (Phase 2)Study completedNCT04107103
What this trial is testing

Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma

Who this might be right for
SCCHN
AHS Cancer Control Alberta 6
Very early researchUnknownNCT05459441
What this trial is testing

Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases

Who this might be right for
GliomaBrain Metastases
Shanghai Pudong Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT03623776
What this trial is testing

Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.

Who this might be right for
Efficacy and Safety
Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT04042558
What this trial is testing

A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVEGFR Gene Mutation+2 more
Centre Francois Baclesse 150
Early research (Phase 1)Study completedNCT02639091
What this trial is testing

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Who this might be right for
Medical Oncology
Bayer 36
Early research (Phase 1)Ended earlyNCT01187615
What this trial is testing

Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 9
Large-scale testing (Phase 3)Study completedNCT01420718
What this trial is testing

Partial Pulpotomy on Caries Free Human Teeth

Who this might be right for
Dentin BridgePulpitis
Islamic Azad University, Sanandaj 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06155279
What this trial is testing

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

Who this might be right for
Pleural Mesothelioma
Istituto Oncologico Veneto IRCCS 41
Not applicableStudy completedNCT07184151
What this trial is testing

Evaluation of Guided Endodontic Microsurgery and Two Different Retrograde Filling Materials

Who this might be right for
Endodontic Re-treatment Failure
Suez Canal University 24
Testing effectiveness (Phase 2)UnknownNCT02951637
What this trial is testing

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Who this might be right for
Lung Adenocarcinoma
Shanghai Chest Hospital 300
Early research (Phase 1)Ended earlyNCT00369629
What this trial is testing

Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Lymphoma
Northwestern University 14
Large-scale testing (Phase 3)Study completedNCT02864251
What this trial is testing

Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy

Who this might be right for
Non-Small-Cell Lung Carcinoma
Bristol-Myers Squibb 367
Not applicableEnrolling By InvitationNCT06973057
What this trial is testing

Direct Pulp Capping Versus Pulpotomy for Primary Molars

Who this might be right for
Vital Pulp Therapies
King Abdullah University Hospital 60
Early research (Phase 1)Study completedNCT00916630
What this trial is testing

Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)

Who this might be right for
Central Nervous System Lymphoma
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT05681195
What this trial is testing

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Who this might be right for
Primary Central Nervous System LymphomaSecondary Central Nervous System LymphomaRelapsed Cancer+1 more
Baptist Health South Florida 15
Testing effectiveness (Phase 2)WithdrawnNCT03843853
What this trial is testing

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
The First Affiliated Hospital with Nanjing Medical University
Testing effectiveness (Phase 2)Study completedNCT00230542
What this trial is testing

Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Dana-Farber Cancer Institute 44
Early research (Phase 1)Ended earlyNCT01918761
What this trial is testing

Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Central European Cooperative Oncology Group 5
Not applicableUnknownNCT01600183
What this trial is testing

Safety and Efficacy of the Universal Neonatal Foot Orthosis in the Treatment of Metatarsus Adductus (MTA)

Who this might be right for
Metatarsus AdductusMetatarsus Varus
Unfo Ltd. 50
Testing effectiveness (Phase 2)Ended earlyNCT00475657
What this trial is testing

Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 5
Load More Results